The objective of this review was to perform a systematic review of the beneficial and harmful effects of Fentora for the management of breakthrough pain in cancer patients aged 18 years and older who are already receiving and who are tolerant to continuous opioid therapy for their persistent baseline cancer pain.
http://ift.tt/2wG9atW
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου